Mandate

Vinge advises Ingrid Capacity in its partnership with SEB Nordic Energy’s portfolio company Locus Energy

September 03, 2024 M&A Banking and Finance

Vinge has advised Ingrid Capacity in connection with the entering into a strategic partnership with Locus Energy, a leading Nordic energy infrastructure company owned by SEB Asset Management's fund SEB Nordic Energy.

The partnership will enable the construction of 13 new large-scale battery energy storage systems across southern Sweden, adding an additional 196 MW of flexible capacity to the national grid in price areas SE3 and SE4. The investment is the second largest of its kind in Sweden and the Nordics.

Ingrid Capacity’s business model entails the construction of large-scale battery energy storage facilities in Europe. I Sweden the batteries will e.g. be used to help Svenska Kraftnät and regional and local electricity network companies to secure the energy supply. Ingrid Capacity was founded in 2022, had a revenue of ca MSEK 117 in 2023, and has 50 employees.

The transaction is subject to applicable regulatory approvals.

Vinge's team consisted primarily of Carl Sander, Jonas Bergström, Vilhelm Rondahl, and Matilda Hamner (M&A), Christoffer Thalin and Jonatan Karlsson (Energy), and Helena Göransson and Jolinn Uhlin (Banking & Finance).

For more information, please click here.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025